In 2022, The Power List will once again showcase the most influential and inspirational figures in the cannabis industry across five categories. Who will you nominate?
The message is clear: we need more evidence. But are randomized, controlled trials the answer?
Sitting Down With... Mike Barnes, Chief Medical Officer, Lyphe Group, London, UK and Chairman, Maple Tree Consultancy, Chester, UK.
Restrictive legislation won’t prevent efforts to progress cannabis research
Regulating cannabis vape flavors may have negative consequences for wider cannabis research… Unless industry acts quickly
Ill-considered regulations have resulted in an analytical race to the bottom.
The need for open and ongoing discussion between scientists, clinicians, regulators, and patients has never been clearer.
Scientists must come together to share experiences, accumulate evidence, and bring about change in cannabis policy.
The cannabis universe is evolving rapidly, but how will newcomers shape the field?
Two experts explore the impact that legalization will have on science, business and human health.
How will Bill C-45 impact on Canadian research and education?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
Easy as C-B-C
The Future of Device Regulation
The Damning Consequences of a Prohibitionist’s Approach to Drugs